New treatments for hepatorenal syndrome

Liver Transplantation

Volumn 6, Issue 3, 2000, Pages 287-289

  Arroyo, Vicente ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; PROSTAGLANDIN DERIVATIVE; VASODILATOR AGENT;

ARTERIAL PRESSURE; EDITORIAL; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HEPATORENAL SYNDROME; KIDNEY FAILURE; KIDNEY PERFUSION; LIVER CIRRHOSIS; PARACENTESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA;

EID: 0034080865     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/lv.2000.7569     Document Type: Editorial

References (12)

1. Vesin P. Traverso H. Hirsch-Marie H. Catan R. Línsufissance rénale circulatoire spontané du cirrhotique. Son évolution Sem Hôp Paris 38 1962 3598 3602
2. Hecker R. Sherlock S. Electrolyte and circulatory changes in terminal liver failure Lancet 2 1956 1121 1125
3. Ginès P. Arroyo V. Hepatorenal Syndrome J Am Soc Nephrol 10 1999 1833 1839
4. Arroyo V. Ginès P. Gerbes A.L. Dudley F.J. Gentilini P. Laffi G. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis Heparology 23 1996 164 176
5. Arroyo V. Bataller R. Guevara M. Treatment of hepatorenal syndrome in cirrhosis Arroyo V. Ginès P. Rodés J. Schrier R.W. Ascites and Renal Dysfunction in Liver Disease. Pathogenesis, Diagnosis and Treatment 1999 Blackwell Science Malden, MA 492 510
6. Guevara M. Ginès P. Fernández-Esparrach G. Sort P. Salmerón J.M. Jiménez W. Reversibiliry of hepatorenal syndrome by prolongued administration of ornipressin and plasma volume expansion Hepatology 27 1998 35 41
7. Angeli P. Volpin R. Gerunda G. Craighero R. Roner P. Merenda R. Reversal of type 1 heparorenal syndrome with the administration of midodrine and octeotride Hepatology 29 1999 1690 1697
8. Gülberg V. Bilzer M. Gerbes A.L. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine Hepatology 30 1999 870 875
9. Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W., Salmerón J.M. et.al., Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome, Results of a pilot study. J Hepatol (in press).
10. Guevara M. Ginès P. Bandi J.C. Gilabert R. Sort P. Jiménez W. Transjugular intrahepatic porrosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems Heparology 28 1998 416 422
11. Sort P. Navasa M. Arroyo V. Aldeguer X. Planas R. Ruiz-delArbol L. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 1999 403 409
12. Mitzner S.R. Stange J. Klammt S. Risler T. Erley C.M. Bader B.D. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, controlled clinical trial Liver Transpl 6 2000 277 286